Sort
15,842 grants matching “pancreatic cancer”
Enhancing T Cell Therapy of Cancer
$1,874,319Helen E Heslop · Baylor College Of Medicine · P01 · FY2014 · CA
Cell Cycle Regulation In Oogenesis
$1,873,947Mary A Lilly · Eunice Kennedy Shriver National Institute Of Child Health & Human Development · ZIA · FY2024 · HD
Molecular signatures for liver cancer diagnosis and treatment stratification
$1,870,751Xin Wei Wang · Division Of Basic Sciences - Nci · ZIA · FY2021 · CA
Integrated Immune Engineering for Poor Prognosis Cancers
$1,869,132David J Odde · University Of Minnesota · P01 · FY2023 · CA
Integrated Immune Engineering for Poor Prognosis Cancers
$1,869,132David J Odde · University Of Minnesota · P01 · FY2022 · CA
Immunotherapy for Malignant Mesothelioma and Lung Cancer
$1,865,336Raffit Hassan · Division Of Basic Sciences - Nci · ZIA · FY2020 · CA
Center for Immunotherapeutic Transport Oncophysics
$1,865,321Haifa Shen · Methodist Hospital Research Institute · U54 · FY2018 · CA
Commercializing CivaSheet for Pancreatic Cancer Patients
$1,864,846Kristy Perez · Civatech Oncology, Inc. · R44 · FY2023 · CA
IGF::OT::IGF CORE INFRASTRUCUTE SUPPORT FOR SURVEILLANCE, EPIDEMIOLOGY, AND END RESULTS (SEER) STUDY PERIOD OF PERFORMANCE 05/01/2015-04/30/2016
$1,861,162Carol Sweeney · University Of Utah · N01 · FY2015 · CA
Center for Diagnostic and Therapeutic Strategies in Pancreatic Cancer
$1,860,485Sathish Venkatachalem · North Dakota State University · P20 · FY2024 · GM
Collaborative Research: Next-Generation Model Checking and Abstract Interpretation With a Focus on Embedded Control and Systems Biology
$1,858,340Scott A Smolka · Suny At Stony Brook · · FY2009 · CSE
Post-transcriptional Regulation Of Proliferative and Stress Response Genes
$1,858,187Myriam Gorospe · National Institute On Aging · ZIA · FY2012 · AG
CENTER FOR ALCOHOLIC LIVER AND PANCREATIC INJURY
$1,856,997University Of Southern California · P50 · FY2003 · AA
The role of the macroenvironment in pancreatic cancer-induced cachexia
$1,855,958Denis C Guttridge · Medical University Of South Carolina · P01 · FY2025 · CA
Development of antibody engineering-based cancer therapies
$1,851,352Mitchell Ho · Division Of Basic Sciences - Nci · ZIA · FY2023 · CA
Defining neoantigen immunodominance for antigen selection and biomarker discovery in human pancreatic cancer immunotherapy
$1,850,296Vinod P Balachandran · Sloan-Kettering Inst Can Research · U01 · FY2017 · CA
Texas Center for Cancer Nanomedicine
$1,850,049David G. Gorenstein · University Of Texas Hlth Sci Ctr Houston · U54 · FY2013 · CA
Collaborative Research: Next-Generation Model Checking and Abstract Interpretation with a Focus on Embedded Control and Systems Biology
$1,848,083W. Rance Cleaveland · University Of Maryland, College Park · · FY2009 · CSE
Collaborative Research: Next-Generation Model Checking and Abstract Interpretation with a Focus on Embedded Control and Systems Biology
$1,848,082Bhubaneswar Mishra · New York University · · FY2009 · CSE
Disrupting the immune and drug-privileged microenvironment in pancreas cancer
$1,846,829Sunil R Hingorani · Fred Hutchinson Cancer Research Center · U01 · FY2017 · CA
Center for Immunotherapeutic Transport Oncophysics
$1,845,151Mauro Ferrari · Methodist Hospital Research Institute · U54 · FY2017 · CA
Systematic interrogation of the pancreatic cancer microenvironment in patient-derived specimens
$1,845,039William C Hahn · Dana-Farber Cancer Inst · U01 · FY2017 · CA
Mechanisms of non-classical multidrug resistance in cancer
$1,844,598Michael Gottesman · Division Of Basic Sciences - Nci · ZIA · FY2025 · CA
Genetics and Biology of Pancreatic Duct Adenocarcinoma
$1,838,383Ronald Anthony Depinho · Dana-Farber Cancer Inst · P01 · FY2009 · CA
SPORE IN GASTOINTESTINAL CANCER
$1,831,625University Of Nebraska Medical Center · P50 · FY2000 · CA